EP1.18-19 Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice

Saved in:

Bibliographic Details
Published in	Journal of thoracic oncology Vol. 14; no. 10; p. S1103
Main Authors	Furuhashi, K., Hataji, O., Nakamura, Y., Suzuki, Y., Sakaguchi, T., Ito, K., Fujiwara, K., Nishii, Y., Taguchi, O.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.10.2019
Online Access	Get full text

Loading…

Be the first to leave a comment!